I’m a holder and like the company very much, but isn’t it very optimistic to assume a PE of 22.48 for the COVID-19 related revenue? To attract this kind of PE you would generally be expecting the earnings to grow for quite some time into the future. In reality, it seems likely that COVID-19 related revenue will drop off steeply in future years (assuming a vaccine is found).
COVID-19 ARDS and ARDS Share Price Scenarios, page-9
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |